Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Late Effect of Ablation on Premature Ventricular Complex Ablation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03249545
Recruitment Status : Unknown
Verified August 2017 by Fırat Özcan, Yuksek Ihtisas Hospital.
Recruitment status was:  Recruiting
First Posted : August 15, 2017
Last Update Posted : August 15, 2017
Sponsor:
Information provided by (Responsible Party):
Fırat Özcan, Yuksek Ihtisas Hospital

Brief Summary:
Premature Ventricular Complex (PVC) ablation is performed in certain indications. Generally acutely abolition of PVC at the time of ablation accepted as successful ablation. However in some patients this effect occurs lately. In this study investigators sought late effect of ablation

Condition or disease
Premature Ventricular Complex Electrophysiology Ablation

Detailed Description:
On tissue level ablation lesion deepens and enlarges by time following the procedure. Based on this, investigators aimed to seek patients who has no acute success but late success. This phenomenon occurs in some patients. Investigators investigate the characteristics of those patients on both procedural and clinical aspects. Investigators enroll patients applied during prespecified dates

Layout table for study information
Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Late Effect of Ablation on Premature Ventricular Complex Ablation
Actual Study Start Date : July 1, 2017
Estimated Primary Completion Date : December 31, 2018
Estimated Study Completion Date : March 1, 2019



Primary Outcome Measures :
  1. Success [ Time Frame: 3 months ]
    Continuation of ablation on the long term



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals having premature complexes and matching ablation indications are included and selection will be based on above mentioned criteria
Criteria

Inclusion Criteria:

Patients who had both of the criteria below

  • Presence of premature ventricular complex requiring ablation
  • Successfully abolition of premature ventricular complex hours after the procedure

Exclusion Criteria:

Patients who had either of below mentioned criteria

  • Abolition of premature ventricular complex during the procedure
  • Unsuccessful procedure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03249545


Contacts
Layout table for location contacts
Contact: Firat Ozcan, Ass. Prof, MD +905327854000 drfozcan@gmail.com

Locations
Layout table for location information
Turkey
Turkiye Yuksek Ihtisas Training and Research Hospital Recruiting
Ankara, Turkey, 06590
Contact: Firat R Ozcan, Ass. Prof, MD    5327854000    drfozcan@gmail.com   
Sponsors and Collaborators
Yuksek Ihtisas Hospital
Layout table for additonal information
Responsible Party: Fırat Özcan, MD,Associate Profesor, Yuksek Ihtisas Hospital
ClinicalTrials.gov Identifier: NCT03249545    
Other Study ID Numbers: ozcan02
First Posted: August 15, 2017    Key Record Dates
Last Update Posted: August 15, 2017
Last Verified: August 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Premature Birth
Ventricular Premature Complexes
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Cardiac Complexes, Premature
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Cardiac Conduction System Disease
Pathologic Processes